BIOGEN INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2015-06-30 was 30.00K shares, a 21.05% decline year-over-year.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2015-03-31 was 68.00K shares, a 8.11% decline year-over-year.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2014-12-31 was 30.00K shares, a 18.92% decline year-over-year.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2014-09-30 was 38.00K shares, a 20.83% decline year-over-year.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 6.20M shares, a 0.00% change from fiscal 2018.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for fiscal 2018 was 6.20M shares, a 0.00% change from fiscal 2017.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for fiscal 2017 was 6.20M shares, a 0.00% change from fiscal 2016.
- BIOGEN INC. stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 6.20M shares, a 0.00% change from fiscal 2015.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2019-12-31 | 6.20M shares 10-K · filed 2020-02-06 | |
| 2018-12-31 | 6.20M shares 10-K · filed 2019-02-06 | |
| 2017-12-31 | 6.20M shares 10-K · filed 2018-02-01 | |
| 2016-12-31 | 6.20M shares 10-K · filed 2017-02-02 | |
| 2015-12-31 | 6.20M shares 10-K · filed 2016-02-03 | |
| 2015-06-30 | 30.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | 166.00K shares derived: sum of 4 quarters · filed 2015-07-24 |
| 2015-03-31 | 68.00K shares 10-Q · filed 2015-04-24 | 174.00K shares derived: sum of 4 quarters · filed 2015-07-24 |
| 2014-12-31 | 30.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | 180.00K shares 10-K · filed 2015-02-04 |
| 2014-09-30 | 38.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | 187.00K shares derived: sum of 4 quarters · filed 2015-07-24 |
| 2014-06-30 | 38.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | 197.00K shares derived: sum of 4 quarters · filed 2015-07-24 |
| 2014-03-31 | 74.00K shares 10-Q · filed 2015-04-24 | 207.00K shares derived: sum of 4 quarters · filed 2015-04-24 |
| 2013-12-31 | 37.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | 245.00K shares 10-K · filed 2015-02-04 |
| 2013-09-30 | 48.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | 257.00K shares derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-06-30 | 48.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | 266.00K shares derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-03-31 | 112.00K shares 10-Q · filed 2014-04-23 | 280.00K shares derived: sum of 4 quarters · filed 2015-02-04 |
| 2012-12-31 | 49.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | 274.00K shares 10-K · filed 2015-02-04 |
| 2012-09-30 | 57.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | 277.00K shares derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-06-30 | 62.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | 286.00K shares derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-03-31 | 106.00K shares 10-Q · filed 2013-04-25 | 355.00K shares derived: sum of 4 quarters · filed 2014-02-06 |
| 2011-12-31 | 52.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | 434.00K shares 10-K · filed 2014-02-06 |
| 2011-09-30 | 66.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | 525.00K shares derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-06-30 | 131.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | 581.00K shares derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-03-31 | 185.00K shares 10-Q · filed 2012-05-01 | 585.00K shares derived: sum of 4 quarters · filed 2013-02-05 |
| 2010-12-31 | 143.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | 600.00K shares 10-K · filed 2013-02-05 |
| 2010-09-30 | 122.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | 631.00K shares derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-06-30 | 135.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | 620.00K shares derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-03-31 | 200.00K shares 10-Q · filed 2011-04-21 | |
| 2009-12-31 | 174.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | 600.00K shares 10-K · filed 2012-02-03 |
| 2009-09-30 | 111.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | |
| 2008-12-31 | 500.00K shares 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |